We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$108M
(+155%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
60.42%
Top 10 Holdings %
Top 10 Hldgs %
3.93%
Holding
829
New
562
Increased
57
Reduced
34
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprouts Farmers Market
SFM
|
+$969K |
| 2 |
TIGR
UP Fintech Holding
TIGR
|
+$737K |
| 3 |
Corporacion America
CAAP
|
+$729K |
| 4 |
LX
LexinFintech Holdings
LX
|
+$728K |
| 5 |
Wayfair
W
|
+$720K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cirrus Logic
CRUS
|
+$563K |
| 2 |
Monster Beverage
MNST
|
+$526K |
| 3 |
Clorox
CLX
|
+$510K |
| 4 |
Okta
OKTA
|
+$488K |
| 5 |
Nordson
NDSN
|
+$480K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 13.71% |
| 4 | Consumer Discretionary | 13.67% |
| 5 | Industrials | 13.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Artesian Resources
ARTNA
$362M
| $210K | 0.12% |
+6,450
| New | +$214K |
|
477
Peoples Bancorp
PEBO
$1.51B
| $210K | 0.12% |
+7,005
| New | +$212K |
|
478
Align Technology
ALGN
$12.9B
| $210K | 0.12% |
+1,677
| New | +$263K |
|
479
Mission Produce
AVO
$1.13B
| $210K | 0.12% |
+17,453
| New | +$215K |
|
480
Chewy
CHWY
$9.35B
| $210K | 0.12% |
5,184
-252
| -5% | -$9.72K |
|
481
Scotiabank
BNS
$106B
| $210K | 0.12% |
+3,241
| New | +$191K |
|
482
EverQuote
EVER
$958M
| $209K | 0.12% |
+9,158
| New | +$221K |
|
483
Genie Energy
GNE
$375M
| $209K | 0.12% |
+14,008
| New | +$251K |
|
484
Contango Silver & Gold Inc
CTGO
$510M
| $208K | 0.12% |
+8,327
| New | +$177K |
|
485
Cognyte Software
CGNT
$655M
| $208K | 0.12% |
+24,711
| New | +$219K |
|
486
Lands' End
LE
$375M
| $207K | 0.12% |
+14,678
| New | +$196K |
|
487
Cytokinetics
CYTK
$10.7B
| $207K | 0.12% |
+3,765
| New | +$155K |
|
488
DaVita
DVA
$15.5B
| $207K | 0.12% |
+1,557
| New | +$214K |
|
489
John B. Sanfilippo & Son
JBSS
$993M
| $207K | 0.12% |
+3,217
| New | +$208K |
|
490
TriMas Corp
TRS
$1.41B
| $207K | 0.12% |
+5,345
| New | +$190K |
|
491
Fomento Económico Mexicano
FMX
$42.1B
| $206K | 0.12% |
+2,093
| New | +$195K |
|
492
McKesson
MCK
$106B
| $206K | 0.12% |
267
-86
| -24% | -$60.6K |
|
493
HUB Group
HUBG
$2.88B
| $206K | 0.12% |
+5,987
| New | +$214K |
|
|
DOCU
494
DocuSign
DOCU
$11B
| $206K | 0.12% |
+2,851
| New | +$220K |
|
495
MP Materials
MP
$7.02B
| $206K | 0.12% |
+3,064
| New | +$193K |
|
496
NewMarket
NEU
$7.09B
| $205K | 0.12% |
+248
| New | +$191K |
|
|
RHLD
497
Resolute Holdings Management
RHLD
$1.04B
| $205K | 0.12% |
+2,845
| New | +$154K |
|
498
The RMR Group
RMR
$337M
| $205K | 0.12% |
+13,047
| New | +$218K |
|
499
Union Pacific
UNP
$173B
| $205K | 0.12% |
+867
| New | +$195K |
|
500
HCA Healthcare
HCA
$91.2B
| $204K | 0.11% |
+479
| New | +$186K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, PharVision Advisers held 829 positions worth $178M, up 155% from $69.6M the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.
PharVision Advisers deployed $107M of net new capital in Q3 2025, opening 562 new positions and adding to 57 existing holdings. Its largest new stake was Sprouts Farmers Market: 6,658 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Western Union, an estimated $321K trimmed.
- PharVision Advisers's largest Q3 2025 buy was Sprouts Farmers Market: 6,658 shares worth $724K.
- PharVision Advisers added most to Gogo Inc in Q3 2025, an estimated $397K increase.
- PharVision Advisers's biggest Q3 2025 reduction was Western Union, cutting an estimated $321K.
- PharVision Advisers fully exited Cirrus Logic in Q3 2025, selling an estimated $563K.
- PharVision Advisers's ten largest holdings make up 3.9% of its $178M portfolio in Q3 2025.
- PharVision Advisers opened 562 new positions and closed 175 in Q3 2025.
- PharVision Advisers's portfolio value rose 155% quarter-over-quarter to $178M.
Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.